Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-31 @ 11:36 AM
Study NCT ID:
NCT01685060
Status:
COMPLETED
Last Update Posted:
2017-06-19
First Post:
2012-09-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11-26
Start Date Type:
ACTUAL
Primary Completion Date:
2016-03-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03-29
Completion Date Type:
ACTUAL
First Submit Date:
2012-09-04
First Submit QC Date:
None
Study First Post Date:
2012-09-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-27
Results First Submit QC Date:
None
Results First Post Date:
2017-05-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-25
Last Update Post Date:
2017-06-19
Last Update Post Date Type:
ACTUAL